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ABSTRACT : There has been many atomic bomb survivors in Nagasaki which is 
also one of the endemic areas of adult T-cell leukemia (ATL). ATL is known as virus 
(HTLV-I) induced leukemia. Thirty-seven cases of ATL were found among the atomic 
bomb survivors during the period from 1950 to 1983 by reviewing their blood samples. 
Seventeen cases of them were developed from the cohort study samples of Radiation Effect 
Research Foundation (RERF). The radiation effect for the incidence of ATL was calculated 
using this cohort samples. Increased risk of ATL among the atomic bomb surviors could 
not be found in this study.
       INTRODUCTION 
 Nagasaki is a city which has a history of 
exposure to the atomic bombing as well as a 
high incidence adult T-cell leukemia. There are 
still about 70,000 survivors of the Nagasaki 
atomic bombing. It is well known that the 
incidence of leukemia has incereased as a result 
of exposure to the atomic bomb radiation", while 
ATL is a leukemic disease caused by a virus, 
HTLV-I (human T-cell lymphotropic virus type 
I)2'. Moreover, the infection of local residents 
with the virus does not seem to be a recent 
phenomnon ; it has been suggested that it was 
present more 1,000 years ago. According to an 
epidemiological investigation, 5-10% of the 
adults of the Nagasaki region are carriers of 
HTLV-I3'. 
 It is of grest interest medically to investigate 
how individuals are affected when two specific 
carcinogenic factors, that is, exposure to the 
atomic bombing and infection with HTLV -I, 
act on an individual. Therefore, we examined 
patients with ATL selected from atomic bomb
survivors. Our findings did not suggest that the 
incidence of ATL was significantly higher in 
atomic bomb survivor than in controls. Howe-
ver, it seems that we are not the only ones who 
have an interest in the combination of these two 
carcinogenic factors. We have received inquires 
about our investigation several times. For this 
reason, we decided that it is necessary to report 
the results of the present study, even though 
they are negative.
    SUBJECTS AND METHOD 
 The Department of Internal Medicine, Atomic 
Disease Institute, Nagasaki University School of 
Medicine and the Radiation Effects Research 
Foundation (RERF) have carried out a collabo-
rative study on leukemia, leukemic malignant 
lymphoma and associated diseases occurring 
in and outside Nagasaki City since around 1950. 
The diseases were detected by conducting a 
leukemia registration program, confirming diag-
nosis by obtaining blood samples and carrying 
out a continuous investigation concerning the 
occurrence of these diseases in the atomic bomb
survivors. 
 In order to identify ATL cases among atomic 
bomb survivors based on the registry data, one 
of the aurthors of this report, M. Ichimaru, 
reexamined blood samples from the register-
ed cases. ATL was confirmed by conducting 
morphogical observation of the leukemia cells 
and by studying the clinical charts. Since most 
of the cases were from the past, data concerning 
anti-HTLV-I antibody was unavailable except 
for a few recent cases. 
 In order to analyze the relationship between 
atomic radiation dose and the incidence of ATL, 
we examined the 30,761 atomic bomb survivors 
in the RERF extended life span study cohort 
for whom dose estimates were available, and 
we evaluated the results statistically. 
 The atomic bomb radiation dose estimates 
eatablised in 1965 (T-65D) were used". Although 
the radiation dose in Hiroshima and Nagasaki 
has been reconsidered on an extensive scale 
in recent years and a new dosimetry system, 
DS86'', is now in use, the Nagasaki dose es-
timates do not differ widely between T-65 and 
DS86. Therefore, the T-65 doses were used for
convenience in out study.
          RESULTS 
 In the study period ending December, 1983, 
37 patients suspected to have ATL were found 
among the atomic survivors in Nagasaki as a 
result of the examination of blood samples from 
all the cases with leukemia and leukemic ma-
lignant lymphoma. 
1. The relationship between ATL and exposure 
to the atomic bombing in the 37 ATL cases. 
 Table 1 shows the distribution of the 37 ATL 
cases by sex, age, the period of onset by distance 
from hypocenter and sample classification by 
sex to determine whether or not these 37 cases 
belong to the FERF fixed cohort. The ratio of 
male to female was 3: 2, and 35% of the cases 
were in their 50 years, cleary reflecting the char-
acteristics of age structure of ATL. Looking 
at the distribution by distance from the hypo-
center, 11 cases were proximal survivors (less 
than 2.5Km), and 26 distal survivors. For both 
proximal and distal survivors, the number of
Table 1. Distribution of ATL cases in a-bomb survivors in Nagasaki by sex, age, 
        distance and sample classification, as of Dec. 1983 
                             Sex 
   Age at onset 
Male Female Total 
     <40 3 3 6 
     40-49 7 2 9 
     50-59 7 6 13 
     60-69 2 4 6
     70+ 2 1 3
     Total 21 16 37
                   Distance from the hypocenter (m) 
  Year of onset Total 
                        <2.5Km 2.5-9.9Km 
   1950-1960 2 2 4 
   1961-1970 2 9 11
   1971-1980 5 10 15 
   1981-1983 2 5 7 
     Total 11 26 37
                        Sample classification 
      Sex Total 
                LSS Extended Sample others 
     Male 8 13 21 
     Female 9 7 16
     Total 17 20 37
                                              LSS : life span study
Table 2. Crude incidence rate of ATL in a-bomb survivors in LSS extended sample 
        in Nagasaki, 1950-1983 
                           T65DR total dose (rad) 
   Items Total 
                       0 1-49 50-99 100+ 
                                 Oct. 1950-Dec. 1960 
 Person years (PY) 149018 109107 14261 27104 299490 
 Case 0 2 0 2 4 
 Rate (10-s) 0.0 1.8 0.0 7.4 1.3 
                                 Jan. 1961-Dec. 1970 
 PY 129023 95522 12713 24304 261562 
 Case 5 2 0 0 7 
 Rate (10"5) 3.9 2.1 0.0 0.0 2.7 
                                 Jan. 1971-Dec. 1983 
 PY 144764 108009 14327 27766 294866 
 Case 2 4 0 0 6 
 Rate (10-') 1.4 3.7 0.0 0.0 2.0 
                         Oct. 1950-Dec. 1983 (total period) 
 PY 422804 312638 41301 79175 855918 
 Case 7 8 0 2 17 
 Rate (10-5) 1.7 2.6 0.0 2.5 2.0 
 Note : Excluding unknown dose
Table 3. Summary of regression analysis and 
        analysis of dose effect for ATL incidence
        in a-bomb survivors in LSS extended 
        sample in Nagasaki, 1950-1983 
1. Relative risk model 
   As = Aos (1+/31D) 
 Strata = Sex, 3 age ATB group (0-19, 20-39, 40+) 
     D = 4 dose group (0, 1-49, 50-99, 100+) 
   Parameter 
       Name Esitimates S. E. 
     Dose 6/30 0.3229E-3 0.3057E-2 
   Test of dose effect : X2 = 0.01 N. S. 
               [1]
2. Relative risk model with multiplicative risk 
  function (Loglinear model) 
     A = e#o+f4,Sex+flzlog•ageATB+flaDose 
   Parameter 
       Name Estimates S. E. 
 Constant (fio) -13.26 1.166
 Sex (91) 0.3612 0.4880 
 Log Age ATB (,82) 0.7444 0.3403 
 Dose 03) 0.4728E-3 0.2778E-2 
  Test of dose effect : X2 = 0.028 N. S. 
               [1]
3. Additive model 
    A = eRo+R,Sex+,Bzlog•ageATB+, 3Dose 
   Parameter 
       Name Estimates S. E. 
 Constant (,3) -13.35 1.221 
Sex 01) 0.3915 0.4989 
Log Age ATB (/32) 0.7636 0.3511 
 Dose (/33) 0.1600E-7 0.6321E-7 
  Test of dose effect : X2 = 0.080 N. S. 
               [1]
ATL cases tends to increase in recent years. 
 The 17 cases of these 37 cases belongimg to 
the RERF fixed cohort (LSS extended sample) 
were used to examine the relationship between 
atomic bomb radiation exposure and incidence 
of ATL. 
2. Incidence rates of ATL in the fixed cohort. 
 Table 2 shows the annual crude incidence 
rates of ATL (per 100,000) by three periods and 
by dose. Looking at the rates in the three 
periods, the number of cases shows a decrease, 
but the 2 cases with relatively high dose (more 
than 1Gy) were from the period between 1950 
and 1960. 
 Table 3 shows a summary of the regression
Appendix List of ATL cases in Nagasaki a-bomb survivors until Dec. 1983 
 M. F. # Sex Onset Distance LSS extended 
                    Age Month -- Year (m) Sample 
  008-237 F 52 9 '67 5887 -
  009-812 M 56 9 '58 1152 Yes 
  014-489 F 56 4 - '79 2525 Yes 
  015-885 M 54 8 - '69 3056 -
  017-420 F 29 12 - '57 2600 Yes 
  017-551 M 54 2 '68 4137 Yes 
  019-286 F 57 1 -- '77 2712 Yes 
  021-326 F 65 11 - '79 3209 -
  029-711 M 51 1 - '61 3591 Yes 
  030-702 M 56 5 - '76 5027 -
  032-402 F 58 6 - '80 2049 Yes 
  047-441 M 58 3 - '72 2882 -
  050-624 M 42 7 - '75 3845 -
  056-535 M 76 8 - '68 3186 Yes 
  066-168 M 63 2 - '82 3651 -
  066-560 M 49 11 - '83 3178 Yes 
  085-466 M 25 8 - '55 2537 Yes 
  089-804 F 55 6 - '68 1761 Yes 
  089--834 F 29 7 - '56 1311 Yes 
  092-313 F 37 4 - '73 2394 Yes 
  097-494 F 75 11 - '80 3201 -
  100-852 F 46 12 - '77 4680 -
  102-764 M 57 10 - '68 3812 Yes 
  106-227 M 69 10 - '65 4699 Yes 
  137-854 F 65 9 - '67 2817 Yes 
  165-217 F 69 8 - '74 0682 Yes 
  623-599 M 41 2 - '76 8502 -
  624-773 M 40 11 - '83 2000* -
  662-918 F 50 12 - '79 2193 -
  733-778 M 31 7 - '62 5152 -
  748-969 M 38 5 - '68 4438 -
  761-454 F 46 7 - '75 1563 -
  774-167 M 47 5 - '80 8492 -
  776-735 M 46 7 - '81 2500* -
  777-368 M 47 3 - '82 5000*1* -
  778-261 F 65 1 - '82 4000* -
  780-734 M 70 4 - '81 1500* -
   Distance information from Dept. of Hematology Nagasaki Medical School. 
M. F. # : Master file number of RERF
analysis of dose effects on three statistic models 
using all the cases divided into three age groups 
(0-19, 20-39, 40+) to determine whether or not 
exposure to the atomic bombing affects the 
incidence of ATL. According to our results, no 
significant differences in dose effect were found 
in any of the three modeles. We concluded that 
exposure to atomic bomb radiation does not 
appear to have had an effect on the incidence 
of ATL.
        DISCUSSION 
 It has been found that the incidence of 
leukemia increased in proportion to the radia-
tion dose among atomic bomb survivors in 
Hiroshima and Nagasaki. Although it is clear 
that exposure to the atomic bombing affected 
the incidence, the biological mechanism link-
ing exposure to radiation to the incidence of 
leukemia has not been elucidated.
 Leukemia occurred in only a very limited 
number of atomic survivors even when they had 
been exposed to the same amount of radiation. 
This suggests that several factors in addition 
to the aberration of cells due to the exposure 
to radiation are involved in the onset of 
leukemia. Little has been known about these 
factors. However, the existence of a virus that 
activates genes has been cited as a possible 
factor. Nagasaki underwent the explosion of 
a plutonium atomic bomb and is also a densely 
infected area of HTLV-I, which is suspected as 
a cause of ATL. It seemed important to 
investigate the incidence of cancer when two 
influential carcinogenic factors, that is, exposure 
to radiation and infection with a carcinogenic 
virus, coexist in the same population. From this 
point of view, we studied the relation between 
radiation exposure and ATL in atomic bomb 
survivors. In our study, however, there was no 
evidence that atomic survivors have a higher 
incidence of ATL due to the exposure to ra-
diation. The following are problems involved 
in this study. 
 First, ATL was diagnosed by morphological 
observation of aberrant cells in blood samples. 
Although our diagnosis are not absolutely 
certain, it seems quite possible to diagnose old 
cases with rather high reliability considering the 
characteristics of aberrant cells, because ATL 
cells show distinct morphological features and 
anti-HTLV-I antibody was positive in 100% of 
the ATL cases diagnosed by cell morphology 
in Nagasaki". Lymphoma-type ATL was not 
detected in this study because aberrant cells 
hardly appear in the peripheral blood. In the 
past it was probably considered to be malignant 
lymphoma. Considering the fact that there was 
no evidence of a marked increase of malignant 
lymphoma among the Nagasaki atomic bomb 
survivors'', it is unlikely that only this type of 
ATL increased. The relatively small number 
of ATL cases found between 1950 and 1960 is 
possibly due to the fact that we started our 
leukemia registration program in 1959. 
 Studies equally as deteiled as our investiga-
tion of leukemia seemed to support the conclu-
sion that there is no increase of ATL cases in 
proportion to the amount of radiation dose. 
That is, the combined influence of atomic ra-
diation and HTLV-I in carcinogenesis was not 
evident. 
 The following also lends credibility to our 
conclusion. It is possible that radiation in the 
incidence of leukemia affects the bloods cells 
on a different level than HTLV-I in the incidence 
of ATL. The study of leukemia induced by 
atomic bomb radiation suggests that radiation 
affects hematopoiectic stem cells, which causes 
the onset of leukemia in many cases. In ATL, 
on the other hand, HTLV-I infects to differ-
enciated T-cells (helper T-cells), and T-cells are 
transformed into tumor cells', which causes the 
onset of ATL. The difference in levels of blood 
cells of leukemogenesis might be the reason for 
why the incidence of ATL have not been 
increased among atomic bomb survivors. How-
ever, it is a fact that chromosome aberrations 
apparently caused by radiation are frequently 
observed in the peripheral T-cells of atomic 
survivors`". Moreover, there are other types of 
cancer which show an increase of incidence in 
a different period from leukemia10'. These facts 
indicate the necessity to wait for future 
observations before making a final conclu-
sion.
        CONCLUSION 
 We examined the question of whether or not 
ATL occurring in HTLV-I carriers increases 
among the atomic bomb survivors in Nagasaki, 
but no such evidence was found in the cases 
up to date. 
 Dedicated to the late Dr. Toranosuke Ishimaru, 
co-author of this paper, who passed away 
suddenly after completing the data on the 
statistic analyses for this paper.
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